The article you requested is
Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn
J Clin Psychiatry 2012;73(5):e601-e605
© Copyright 2015 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
A young woman with recurrent major depressive disorder has been reasonably stable on sertraline (150 mg/day) for 2 years. She is childless and plans to conceive, and a risk-benefit analysis suggests that she would do well to continue her medication during pregnancy. Having learned that a new study has shown that her medication doubles the risk of persistent pulmonary hypertension of the newborn (PPHN), she seeks a fresh opinion. This article discusses the methods, findings, strengths, and limitations of the new study and provides information which will help her physician answer the questions that she asks.